Probing the Influence of Cx43 and Glucose on Endothelial Biomechanics by Islam, Md Mydul
University of Central Florida 
STARS 
Electronic Theses and Dissertations, 2004-2019 
2019 
Probing the Influence of Cx43 and Glucose on Endothelial 
Biomechanics 
Md Mydul Islam 
University of Central Florida 
 Part of the Biomechanical Engineering Commons 
Find similar works at: https://stars.library.ucf.edu/etd 
University of Central Florida Libraries http://library.ucf.edu 
This Doctoral Dissertation (Open Access) is brought to you for free and open access by STARS. It has been accepted 
for inclusion in Electronic Theses and Dissertations, 2004-2019 by an authorized administrator of STARS. For more 
information, please contact STARS@ucf.edu. 
STARS Citation 
Islam, Md Mydul, "Probing the Influence of Cx43 and Glucose on Endothelial Biomechanics" (2019). 
Electronic Theses and Dissertations, 2004-2019. 6789. 
https://stars.library.ucf.edu/etd/6789 




B.Sc. Bangladesh University of Engineering and Technology, 2014
A dissertation submitted in partial fulfilment of the requirements
for the degree of Doctor of Philosophy
in the Department of Mechanical and Aerospace Engineering
in the College of Engineering and Computer Science




Major Professor: Robert L. Steward Jr.
© 2019 Md. Mydul Islam
ii
ABSTRACT
Endothelial cells (ECs) form the innermost layer of all vasculature and constantly receive both bio-
chemical and biomechanical signals, yielding a plethora of biomechanical responses. In response
to various biochemical or biomechanical cues, ECs have been documented to generate biomechani-
cal responses such as tractions and intercellular stresses between the cell and substrate and between
adjacent cells in a confluent monolayer, respectively. Thus far, the ability of endothelial tight junc-
tions and adherens junctions to transmit intercellular stresses has been actively investigated, but the
role of gap junctions is currently unknown. In addition, there is no report of the independent influ-
ence of hyperglycemia on endothelial biomechanics present in the literature. To fill these gaps, we
conducted a two-fold study where we investigated the influence of endothelial gap junction Cx43
and hyperglycemia in endothelial tractions and intercellular stress generation. In the first study,
we selectively disrupted and enhanced EC gap junction Cx43 by using 2’,5’-dihydroxychalcone
and retinoic acid, respectively and in the second study, we cultured ECs in both normal glucose
and hyperglycemic condition for 10 days. In both studies, tractions and intercellular stresses were
calculated using traction force microscopy (TFM) and monolayer stress microscopy (MSM), re-
spectively. Our results reveal that Cx43 downregulation increased as well as decreased endothelial
avg. normal intercellular stresses in response to a low (0.83 µM) and a high dose (8.3 µM) chal-
cone treatment, respectively, while Cx43 upregulation decreases avg. normal intercellular stresses
in both treatment conditions (2.5 µM and 25 µM) compared to control. In addition, we observed
a decrease in intercellular stresses with hyperglycemic condition compared to control. The results
we present here represent, for the first time, detailed and comprehensive biomechanical analysis of
endothelial cells under the influence of glucose and the gap junction Cx43. We believe our results
will provide valuable insights into endothelial permeability, barrier strength as well as leading to a
greater understanding of overall endothelial mechanics.
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CHAPTER 1: INTRODUCTION
Gap Junction Cx43 and Endothelium Mechanics
Endothelium maintains over 60 thousands miles of blood vessels in human body [1] [2] [3] [4] [5].
It is the innermost lining of vasculature (figure 1.1) which was once thought to have just a selective
barrier function to control water and some specific molecules entering from blood stream to tissues
[1][2][5]. However, over the time tremendous evidence suggested that this huge endocrine organ
not only performs as a selective barrier to molecules, but also performs critical functions such as
regulation of blood flow, oxygen and nutrients supply to surrounding tissues, takes part in vasodi-
lation and vasoconstriction, angiogenesis or blood vessel formation, prevent thrombosis or blood
clotting, helps to perform clotting when needed, modulates platelet interaction to blood vessel wall
and many more [1][2] [3][4]. Failure to perform such importatnt tasks properly is known as “en-
dothelial dysfunction” which could lead to severe problems such as development of cardiovascular
diseases (e.g. atherosclerosis, hypertension, thrombosis or coronary artery disease), chronic kidney
failure, several viral infections and eventually could lead to a heart attack or a stroke. [1][2][3][4].
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Figure 1.1: Monolayer of endothelial cells
Understandably, injury to endothelium can be severe and may cause widespread damage within
the vasculature. As endothelium loses functionality, it becomes more permeable, impaired va-
sodilation and vasoconstriction occurs, atherosclerotic plaque starts to build up and vascular com-
plications starts to erupt [1][2][3] [4][5].As the innermost layer of vasculature, endothelium con-
stantly receives and delivers plenty of biochemical and biomechanical cues. Researchers have been
working on multi-faceted efforts to improve endothelial health [5] but till today, biochemical fac-
tors involved in endothelium functions such as endothelium derived NO, prostacyclin, endothelin,
thromboxane A2, Vascular Endothelial Growth Factors (VEGFs), angiotensin II remained some of
the major area of research [1] [2] [4] [5].
Although equally important, analysis of endothelial biomechanical responses is still incipient [6].
For example, histamine and thrombin prompts endothelial cells (ECs) to contract and results in
2
increased endothelium permeability [7]. During angiogenesis, protease induced matrix degradation
of existing micro-vessels results in generation of new capillary sprouts, enabling ECs to migrate
into surrounding tissues and form new vessels [8].Furthermore, several groups have showed that
ECs can sense their extracellular matrix (ECM) stiffness and generate tractions accordingly [9]
[10][11]. In fact, in vitro experiments showed HUVEC contractions reduced in a floating collagen
gel concentration of 3mg/mL but increased when collagen concentration decreased to 1.5 mg/mL
[11].
Figure 1.2: Illustration of fluid shear stress (a biomechanical cue) experienced by endothelium.
We present the above examples to highlight two biomechanical events that are essential to en-
dothelial function, contraction and migration. In fact, both contraction and migration require the
generation of tractions [13][14][18] and intercellular stresses [15][16][17]. Forces produced at the
cell-substrate level are actomyosin mediated contractility passed to the ECM via focal adhesions
of the cell and are commonly known as traction forces or simply as “tractions” [6] [21]. On the
other hand, forces at the intercellular level are due to physical interactions between neighboring
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cells in a collective cell sheet and are known as “intercellular stresses” [6][19][20]. While the
cell-substrate traction stresses are mediated in part by focal adhesions(FAs) and actomyosin con-
tractility, intercellular stresses generated within endothelial monolayer have been suggested to be
transmitted through cell-cell junctions (figure 1.3), specifically, adherens junctions(AJs) and tight
junctions (TJs) [22][23][24][25]. Recent studies have suggested endothelial permeability to be
linked to TJs and AJs, which have in turn been suggested to function as mechanosensors capable
of transmitting intercellular stresses [26][27]. Furthermore, endothelial intercellular stresses have
been demonstrated to be responsive to endothelial barrier agonists such as thrombin and histamine
and be cooperative over many cell distances [7]. These examples suggest endothelial cell intercel-
lular stress transmission and generation to be influenced in part by cell-cell junctions, specifically
TJs and AJs [28][29]. However, the role gap junctions play in endothelial cell intercellular stress
generation is currently unknown.
Figure 1.3: Schematic illustration of major endothelial cell-cell junctions and their functions
Gap junctions are a unique family of cell-cell junction proteins that mechanically links adjacent
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cells and provides a physical pathway for electrical current and biomolecules (< 1KDa) to travel
between neighboring cells [30][31]. Endothelial cells primarily express the gap junctions Cx40,
Cx37 and Cx43 [30][31] and deletion or mutation of these gap junctions has been demonstrated
to have a range of vascular ramifications [30][31][32][33]. Such ramifications include increased
risk of hypertension in mice as a result of Cx40 deletion [36] and structural vascular abnormali-
ties in the skin, testis, and intestine in mice [37] as a result of Cx40 and Cx37 genetic deletion.
However, vascular complications yielded from Cx43 deletion are arguably the most severe since
genetic deletion of Cx43 has been demonstrated to induce hypotension in mice [38] and sub-
sequently influence multiple regulatory genes associated with vasculogenesis in mice [39]. In
addition, Cx43 has been reported to be crucial for endothelial cell proliferation, migration [37]
[39] and monocyte-endothelial cell adhesion, a crucial step in inflammation and the initiation and
progression of atherosclerosis [35][40].
Although the above examples clearly suggest Cx43 to play a crucial role in vascular homeosta-
sis, in doing so they also reveal the obscure relationship that exists between Cx43 and endothelial
cell mechanics, which is also essential to vascular homeostasis (Islam et. al., Exp Mechanics, pp:
1-2, [6]). Therefore, to bring clarity to the relationship between Cx43 and endothelial cell me-
chanics, in this study we investigated the role Cx43 plays in endothelial cell intercellular stress
generation and traction generation by manipulating gap junctions Cx43 expression. The main ob-
jective of this study is to selectively down-regulate and up-regulate Cx43 expression and measure
endothelial tractions and intercellular stresses in response to the change in Cx43 expression. To do
this, we seeded Endothelial cells (ECs) as monolayers onto polyacrylamide gels by using circular
micropattern and then exposed them to either 2,5-dihydroxychalcone (chalcone), a known Cx43
expression downregulator[41], or Retinoic Acid (RA), a known Cx43 expression enhancer[40],
in a dose dependent manner. Specifically, confluent HUVEC monolayers were exposed to a low
(0.2 µg/mL or 0.83 µM) and high (2 µg/mL or 8.3 µM) concentration of chalcone and a low (2.5
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µM) and high (25 µM) concentration of RA for a period of total five hours and 24 hours, respec-
tively. At this time, both tractions and intercellular stresses were calculated using traction force
microscopy and monolayer stress microscopy[19]. In addition, cellular velocities and strain energy
produced by cells in both treated and control conditions were also calculated and compared with
respective control condition. Through this study, for the first time, we present the specific role of
gap junction Cx43 plays in endothelial force generation and transmission. We believe our studies
will contribute greatly to the understanding of pathophysiology of severe vascular diseases like
atherosclerosis and hypertension, for example.
Hyperglycemia and Endothelial Dysfunction
The increasing population of diabetic patients causes the diabetes mellitus to become one of the
major health problem in United States [42]. In 2015, over 29 million reported cases are diag-
nosed and according to Center for Disease Control (CDC), diabetes mellitus is one of the ma-
jor cause of cardiovascular diseases in United States [42][43]. Diabetes mellitus can be defined
as host of metabolic conditions associated with the impairment of glucose regulation resulting
in hyperglycemic condition in our body [44]. Numerous experimental and clinical studies have
shown that type-2 diabetes mellitus (with insulin resistant state) increases the chance for endothe-
lial dysfunction [44]. In fact, diabetic patients are 2-4 times more likely to develop cardiovas-
cular diseases (CVDs) than normal person and around 80% of diabetic patients loss their life
from CVDs [44][45][46]. However, many confounding factors such as hyperglycemia, insulin-
resistivity, hyperlipidemia, metabolic disorders and obesity can contribute to the development of
CVDs [44].Therefore, it is difficult to discern the specific role hyperglycemia plays in endothe-
lial dysfunction and subsequently, in the progression of CVDs. For example, multiple studies
have showed that insulin can influence NO-dependent vasodilatory factors as well as production
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of vasoconstricting factors in vasculature while, other studies show that the state of hyperglycemia
can promote impairment of NO activity and may cause disturbance throughout the vasculature
[44] [45][46]. Clinical trials have supported as well as conflicted the independent contribution of
hyperglycemia in the progression of CVDs. Such as postmortem studies of children and young
patient with type-I diabetes showed enhanced fatty streaks in the absence of hyperlipidemia sug-
gesting that hyperglycemia alone may promote early plaque formation [47] [48]. Contrary to
this study, hyperglycemia was strongly found to be associated with early plaque development in
atherosclerosis-prone mice, but the progression of plaques required dyslipidemia [49][50] .
Despite conflicting opinions, there is strong evidence to suggest that hyperglycemia alone con-
tributes greatly to endothelial dysfunction and may lead to life-threatening vascular complications
[44][45][46][47]. Thus far, majority of the studies done focuses mostly on the molecular mech-
anisms of endothelial dysfunction caused by hyperglycemia in diabetic patient. However, the
influence of hyperglycemia on endothelial biomechanical force generation and transmission is yet
to discover. Our objective here is to measure the tractions and intercellular stresses generated by
HUVEC monolayers under the influence of different level of glucose. To do this, we cultured HU-
VECs with normal glucose (5.6 mmol/L of d-glucose), hyperglycemic condition (20 mmol/L of
d-glucose) and with D-mannitol ( 5.6 mmol/L of d-glucose + 14.4 mmol/L of d-mannitol) as os-
motic control. After 10 consecutive days of culture with media supplemented with different level
of glucose, cells were then plated on micropatterned soft substrate gels (E = 1.2 kPa) and were
allowed to grow as circular confluent monolayer for additional 24 hours. At this point, tractions
and intercellular stresses were calculated using traction force microscopy and monolayer stress
microscopy techniques, respectively. Taken together, here we present a unique report of endothe-
lial biomechanical responses under the influence of different glucose conditions. We believe, this
study will contribute to the better understanding of endothelial dysfunction in diabetic patients.
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CHAPTER 2: LITERATURE REVIEW
Traction Force Microscopy (TFM)
In recent years, Traction Force Microscopy (TFM) has become a common tool to measure cell
generated traction forces on a soft elastic substrate [53] [51] [52]. The idea here is to calculate the
displacements induced by cells on a soft substrate which in turn gives the traction forces generated
by cells. To get cell induced substrate displacements, early attempts were devoted to use thin
elastic sheets, but due to its non-linear response quantitative evaluation was hard [51]. To resolve
this issue, thin elastic sheet was replaced by silicon films or Polyacrylamide (PA) films/gels that
deform due to cell contractility [51]. Briefly, fluorescent marker beads were embedded in the PA
gel and then computing bead displacements over time from reference bead positions would give
the required displacement field. Then, solving the inverse problem of elasticity theory would give
reconstructed traction field [51][21]. Another widely used approach is to take advantage of the
elastic displacement of microfabricated pillar arrays that works as strain gauges. Unlike PA gels
where cells form unconstrained adhesion, this method is limited to adhesion sites due to specific
pillar topology. Another excellent alternative is to use molecular force sensors where an elastic
linker is connected to cell domains. Using Förster Resonance Energy Transfer (FRET) one can get
direct fluorescent stress sensor readout as a measurement of force due to elastic linker stretching
by cells [51].
The method we use here is known as Fourier Transform Traction Cytometry (FTTC) and was origi-
nally developed by Butler et. al [21]. Briefly, traction field is defined as local force per unit area (or
stresses) imposed on a soft substrate gel by the cells. From the known traction field, displacement
field can be obtained by utilizing green’s function. This is known as so-called "forward problem"
and the solution to these green’s function for elastic half space and for finite thickness is known as
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"Boussinesq Solution". Typical film thickness used in experiments (50-100 µm) is large compared
to cell induced displacements and boundary condition at the bottom of the substrate doesn’t mat-
ter which allows Boussinesq solution to be used [51]. The problem we solve here is the "inverse
problem", that is getting traction fields from a known displacement field. The FTTC is based on
Fourier analysis and the fact that Fourier transform of a convolution is simply the product of the
Fourier transforms of the functions convolved[21]. Thus, the convolution (equation (0), figure 2.1)
simply becomes the product of Fourier transforms of K(k) and T(k), where k is the wave vector
(equation 1, figure 2.1). Inverse to this equation gives us the desired traction field (equation 2,
figure 2.1). Equation (2) explicitly requires a formula for K(k). The forward kernel in matrix form,
for a point source at (figure 2.1) the origin with zero normal traction is defined as in equation 3
(figure 2.1). Butler et. al. explicitly provides the transformed formula (equation 4, figure 2.1) to
solve for tractions. Flow chart in the figure 2.1 depicts the traction computation formulation and
steps below [21].
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Figure 2.1: Flow chart of traction force field construction using FTTC method.
Once the traction in known, additional analysis can be performed to get contractile moments (figure
2.2, equation 5) and strain energy (figure 2.2, equation 6). The zeroth order moment of the tractions
is equal to the net force applied by the cells to the deformable substrates. In addition, Strain energy,
U , is transferred from cell to the elastic deformation of the substrate, is also another measure of
contractile strength [21]. Taken together, tractions, contractile moments and strain energy can be
used as a robust tool to estimate the relative strength of the cells adhered to a soft substrates.
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Figure 2.2: Equation for contractile moment and strain energy.
FTTC is not regularized so conceptually that can lead to problematic results due to noise present
in the image. Thus, additional image smoothing may need to reduce noise. Moreover, using FTTC
method, unconstrained (no cell boundary) and constrained (specified cell boundary) both type of
2D traction measurement is possible. Furthermore, FTTC is conceptually straightforward and
computationally efficient. It is currently most widely used technique for traction reconstruction
from displacement field [51]. However, displacements have to be measured close to traction field
generated (under cell region is most relevant) to satisfy saint venant’s compatibility equation and
homogeneous distribution of fluorescent marker beads are important as well [21][51].
Monolayer Stress Microscopy (MSM)
An important sub-field of TFM is determining cell-cell intercellular stresses from cell-substrate
tractions by using the idea of force balance in a cell monolayer [19][20]. This method is known as
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monolayer stress microscopy (MSM) and the concept can be easily understood with an example
of tug-of-war contest where the tension or pulling force generated by the contestant in the rope are
equivalent to the pushing force on the ground by the contestant [19][20]. Similar concept can be
applied to a monolayer of cells where cell substrate tractions are balanced by cell-cell intercellular
stresses in a 2D cell plane (figure 2.3).
Figure 2.3: Concept of force balance in monolayer stress microscopy. Local tractions applied by
cells (red) are balanced by long range intercellular stresses (blue).
Intercellular stresses are crucial for understanding collective migratory behavior of cells which is
important for many cellular processes such as wound healing, cancer metastasis or tissue repair[19]
[6] [53] [54] [55]. For example, endothelial cells form the inner lumen of the vasculature and their
collective migratory behavior is important to protect the body from the invasion of harmful sub-
stance. One study by Hardin et. al. reported that endothelial force correlation length increases and
decreases in the presence of agonists and antagonists, respectively. suggesting endothelial barrier
integrity are impacted by the presence of agonists and antagonists[56]. Another study suggested
that endothelial paracellular gap formation may be linked to endothelial intercellular stress gener-
ation in the presence of agonists and antagonists [57]. Ultimately, the knowledge we obtain from
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tractions and subsequent intercellular stress analysis further increases our understanding of funda-
mental cellular processes such as collective cell migration, wound healing, angiogenesis, immune
response, tissue morphogenesis as well as progression of diseases such as cancer cell migration,
for example [19] [20] [6] [53] [54] [55] [58].
Analysis of MSM starts with the cell-substrate 2D traction forces in a cell sheet and then performs
a straightforward force balance (figure 2.4a) within the entire monolayer as demanded by Newton’s
law (equation 1, figure 2.4) to obtain the intercellular stresses [20]. The monolayer here is treated
as isotropic, homogeneous and a thin elastic sheet [20]. If the monolayer Young’s modulus is
defined as E and Poisson’s ratio ν, then we can obtain stress-strain relationship of the substrate
(equation 2, figure 2.4) [20].
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Figure 2.4: Balance of forces in MSM. (a) Monolayer is considered as thin elastic sheet where
each cell exerts force on adjacent cells and the force balance is considered only in 2D plane (b)
Governing equations to solve for monolayer intercellular stresses within the entire monolayer. (c)
formulation of average normal intercellular stress and maximum shear intercellular stress.
In MSM, a standard Finite Element Modeling (FEM) is performed to determine stresses within the
entire monolayer (figure 2.4b) [20]. In brief, monolayer stress microscopy applies a straightfor-
ward force balance required by Newton’s law to give us the two-dimensional stress tensor within
the entire cellular monolayer and by rotating the coordinate system we compute the maximum prin-
cipal stresses (σmax) and minimum principal stresses (σmin) with their respective orientations. At
each point of the monolayer, we then compute the average normal intercellular stress as (σmax +
σmin)/2 and the maximum shear intercellular stress as (σmax - σmin)/2 (figure 2.4c) [20].
A key assumption here is that the cell monolayer can be treated as a thin elastic sheet because
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the traction distribution in the monolayer is known and the force balance does not depend on cell
material properties [19]. Another important assumption is that the traction forces are balanced by
local intercellular stresses within the optical field of view (within the monolayer) and the influence
of this force balance is minimal in the distal region (outside of the monolayer) [19]. Therefore,
the boundary conditions defined by intercellular stresses, displacements, or a combination of both
at the monolayer boundary are crucial to perform MSM. Other errors associated with substrate
geometry and boundary conditions are minimal and described in detail by Tambe et. al. [19] [20].
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CHAPTER 3: PROBING ENDOTHELIAL CELL MECHANICS
THROUGH CONNEXIN 43 DISRUPTION
Abstract
The endothelium has been established to generate intercellular stresses and suggested to transmit
these intercellular stresses through cell-cell junctions, such as VE-Cadherin and ZO-1, for example.
Although the previously mentioned molecules reflect the appreciable contributions both adherens
junctions and tight junctions are believed to have in endothelial cell intercellular stresses, in do-
ing so they also reveal the obscure relationship that exists between gap junctions and intercellular
stresses. Therefore, to bring clarity to this relationship we disrupted expression of the endothe-
lial gap junction connexin 43 (Cx43) by exposing confluent human umbilical vein endothelial
cells (HUVECs) to a low (0.2 µg/mL) and high (2 µg/mL) concentration of 2,5-dihydroxychalcone
(chalcone), a known Cx43 inhibitor. To evaluate the impact Cx43 disruption had on endothelial cell
mechanics we utilized traction force microscopy and monolayer stress microscopy to measure cell-
substrate tractions and cell-cell intercellular stresses, respectively. HUVEC monolayers exposed
to a low concentration of chalcone produced average normal intercellular stresses that were on
average 17% higher relative to control, while exposure to a high concentration of chalcone yielded
average normal intercellular stresses that were on average 55% lower when compared to control
HUVEC monolayers. HUVEC maximum shear intercellular stresses were observed to decrease
by 16% (low chalcone concentration) and 66% (high chalcone concentration), while tractions ex-
hibited an almost 2-fold decrease under high chalcone concentration. In addition, monolayer cell
velocities were observed to decrease by 19% and 35% at low chalcone and high chalcone concen-
trations, respectively. Strain energies were also observed to decrease by 32% and 85% at low and
high concentration of chalcone treatment, respectively, when compared to control. The findings
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we present here reveal for the first time the contribution Cx43 has to endothelial biomechanics.
———————————————————–
** Islam, M.M. & Steward, R.L., “Probing Endothelial Cell Mechanics Through Connexin43 Dis-
ruption”, Exp Mech (2018). https://doi.org/10.1007/s11340-018-004454. (Full copyright license
is attached in Appendix A)
Materials and Methods
Cell Culture
Human umbilical vein endothelial cells (HUVECs) were purchased commercially from Ther-
moFisher and cultured in medium 200 (ThermoFisher) supplemented with large vessel endothelial
supplement (ThermoFisher) and 1% penicillin-streptomycin (Corning) on 0.1% gelatin (Sigma-
Aldrich) coated flasks at 37°C and 5% CO2. HUVECs were used at passages 8-9 for all experi-
ments.
Polyacrylamide Gel Fabrication
Polyacrylamide gels (PA gels) of stiffness 1.2 kPa were prepared as described previously [54].
Briefly, 35 mm petri dishes (20mm well, Cellvis) were treated with a bind silane solution for 45
mins and then air-dried before hydrogel polymerization. PA gel solution was prepared by mix-
ing ultra-pure water, 40% acrylamide (Bio-Rad) and 2% bis-acrylamide (Bio-Rad). Before poly-
merization 0.5 µm diameter red fluorescent carboxylate-modified microspheres beads (Invitrogen)
were added in the gel solution and then the solution was de-gassed for 45 mins. Subsequently, am-
monium persulfate and TEMED (N,N,N’,N’-tetramethylethane-1,2-diamine) was added to poly-
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merize the gel on the treated petri dishes. Gels were flattened by using 18mm circular coverslips
(ThermoFisher), yielding a gel height of 100 µm (confirmed by fluorescence microscopy).
Table 3.1: PA Gel Making Components
Total Solution (15 mL) Young’s Modulus (1200 Pa)
Ultra-pure water 12.49 mL
40% Acrylamide 2.062 mL
2% Bis-acrylamide 375 µL
0.5 µm Fluorescent Carboxylate Red Beads 80 µL
Table 3.2: Polymerizing Agents
10% Ammonium Persulfate 75 µL
TEMED 8 µL
Cellular Micropattern Preparation
Micropatterns were fabricated from thin polydimethylsiloxane (PDMS) sections as described pre-
viously [54]. Briefly, a thin layer of PDMS (Dow Corning) was first cured in a 100 mm petri dish
by mixing silicon base with a curing agent (20:1) overnight at room temperature. After fabrication,
a circular PDMS section (16mm diameter) was removed using a hole puncher and subsequently a
1.25 mm diameter biopsy punch (world precision instruments) was used to puncture holes. PDMS
micropattern stamps were then placed on top of PA gels and patterned gels were then treated with
18
sulfosuccinimidyl-6-(4-azido-2-nitrophenylamino) hexanoate (Sulfo-SANPAH; Proteochem) dis-
solved in 0.1 M HEPES buffer solution (Fisher Scientific) and placed under a UV lamp for 8
mins. After SANPAH burning, patterned gels were treated with 0.1mg/ml of collagen I (Advanced
Biomatrix) overnight at 4°C. The following day, excess collagen was removed and HUVECs were
seeded at a concentration of 50×104 Cells/mL and were allowed to attach for an hour. After an
hour, micropatterns were removed and HUVEC’s were then allowed to form confluent monolayers
for at least 36 hours prior to experimentation.
2,5 Dihydroxychalcone Treatment
2,5 dihydroxychalcone (chalcone) (Sigma-Aldrich) was dissolved in dimethylsulfoxide (DMSO),
(Fisher Scientific) as a stock solution at a concentration of 187.5 µg/mL. For Cx43 disruption ex-
periments the previously mentioned stock solution was further diluted and added to cell culture
media to obtain a final low concentration (0.2 µg/mL) and high concentration (2 µg/mL) of chal-
cone.
Time Lapse Microscopy
Phase contrast and fluorescent images were acquired every 5 minutes using a Zeiss inverted micro-
scope with a 10X objective and Hamamatsu camera. Micropatterned HUVEC monolayers were
initially imaged in chalcone-free medium for 1 hour. After this time chalcone-free media was re-
placed with cell culture medium supplemented with either a low or high chalcone concentration
and HUVEC monolayers were subsequently imaged for an additional 5 hours. After this time,
HUVEC monolayers were incubated with 10x trypsin for 10 minutes to remove cells from the gel




Micro-pattered, HUVEC monolayers were first fixed with 4% formaldehyde and incubated at 37°C
for 15 mins, followed by permeabilization with 0.2% Triton-X 100 for 5 mins at 37°C. After per-
meabilization, HUVEC monolayers were incubated with a 2% BSA blocking solution at 37°C
and subsequently incubated with a mouse monoclonal Cx43 antibody at a concentration of 1:400
(CX-1B1, Thermo-fisher) overnight at 4°C. The following day, HUVEC monolayers were incu-
bated with Alexa Fluro 488 goat anti-mouse IgG (ThermoFisher, Catalog A-11001) and Alexa
Flouro 594 phalloidin both at a concentration of 3:200 for 2 hours. Cells were then mounted with
uoromount-G with DAPI, sealed under a coverslip, and imaged using a Zeiss Inverted microscope
(Axio Observer).
Traction Force Microscopy(TFM) and Monolayer Stress Microscopy(MSM)
Traction force microscopy and monolayer microscopy was used as described previously [54][19][6].
Briefly, substrate gel deformations produced by the cell was calculated using a particle image ve-
locimetry (PIV) routine and cell-substrate forces were calculated using fourier transform traction
force microscopy [21]. Intercellular stresses were calculated using monolayer stress microscopy
as described previously [19][6]. In brief, monolayer stress microscopy applies a straightforward
force balance required by Newton’s law to give us the two-dimensional stress tensor within the en-
tire cellular monolayer and by rotating the coordinate system we compute the maximum principal
stresses (σmax) and minimum principal stresses (σmin) with their respective orientations. At each
point of the monolayer we then computed average normal intercellular stress (σmax + σmin)/2 and
maximum shear intercellular stress (σmax - σmin)/2.
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Measurement of Cell Velocity
Cell velocity was measured from phase contrast images using a custom-written PIV routine in
MATLAB. Briefly, our PIV routine was used to calculate window shifts between sequential images
and then pixel shifts were converted into displacements by multiplying with the pixel to micron
conversion factor. Displacements were then averaged for each time points and converted into
velocity. Images were taken in a time interval of 5 mins for 6 hours.
Results
2,5 Dihydroxychalcone Reduces Cx43 Expression
Before we investigated the influence Cx43 disruption via 2,5 dihydroxychalcone had on endothelial
cell biomechanics we first wanted to investigate the influence 2,5 dihydroxychalcone had on Cx43
structure.
21
Figure 3.1: Effect of chalcone treatment on Cx43 structure. Immunostaining was performed in
HUVEC monolayers after 6 hours of chalcone treatment. Green color represents Cx43 and Blue
represents DAPI. Figure labels are as follows- control (a, b, and c), 0.2 µg/mL chalcone treated
cells (d, e, and f) and 2µg/mL chalcone treated cells (g, h, and i). (obj: 20x; scale bar (represent
entire image length) = 200 µm)
Our results revealed fluorescent images of Cx43 structure under low chalcone concentration (fig-
ure 3.1d, e and f) to look almost structurally indistinguishable when compared to control groups
(figure 3.1a, b and c). However, Cx43 structure under high chalcone concentration (figure 3.1g,
h and i) was observed to decrease dramatically when compared to control conditions (figure 3.1),
suggesting reduction of Cx43 expression by 2,5 dihydroxychalcone to be concentration dependent.
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Our results agree with those reported previously by Lee et al. [41]. We also stained for F-actin to
determine if Cx43 disruption influenced actin cytoskeletal structure and actin structure remained
intact and similar for all chalcone treatment conditions (supplementary figure 3.12).
Cx43 Disruption Reduces Intercellular Stresses
Analysis of all results was performed over a cropped 500 x 500 µm section within the middle
of the 1.25 mm micropatterned monolayer. Phase contrast images of control and chalcone treated
conditions 30 minutes before chalcone treatment and after chalcone treatment (2 hours and 6 hours)
are shown in figure 3.2.
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Figure 3.2: Phase contrast images of HUVEC monolayers after Cx43 disruption. Control phase
contrast images of HUVECs at 30 mins (a), 2 hours (b) and 6 hours (c). Phase contrast images
of HUVECs treated with 0.2µg/mL chalcone at 30 mins (d), 2 hours (e) and 6 hours (f). Phase
contrast images of HUVECs treated with 2µg/mL chalcone at 30 mins (g), 2 hours (h) and 6 hours
(i). Scale bar 500 x 500 µm (represent entire image)
Thirty minutes prior to chalcone treatment, average normal intercellular stresses were largely ten-
sile and fluctuated around 220 ± 66 Pa for control, low chalcone treated, and high chalcone treated
HUVECs (figure 3.3a, d and g). Two hours after chalcone treatment average normal intercellular
stresses were around 285 ± 75 Pa and 106 ± 4 Pa at low chalcone treatment (figure 3.3e) and high
chalcone treatment (2 µg/mL) (figure 3.3h) conditions, while control monolayers were around 235
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± 18 Pa (figure 3.3b). After 6 hours, average normal intercellular stresses were observed to be
around 266 ± 22 Pa, 149 ± 30 Pa, and 249 ± 29 Pa for 0.2 µg/mL chalcone treated monolayers
(figure 3.3f), 2 µg/mL chalcone treated monolayers (figure 3.3i), and control monolayers (figure
3.3c), respectively.
Figure 3.3: Average normal intercellular stresses (Pa) of HUVEC monolayers during Cx43 inhibi-
tion. Figure labels show average normal intercellular stresses of HUVECs at 30 mins (a), 2 hours
(b) and 6 hours (c) of control HUVECs and at 30 mins (d), 2 hours (e) and 6 hours (f) of HUVECs
treated with 0.2µg/mL chalcone and at 30 mins (g), 2 hours (h) and 6 hours (i) of HUVECs treated
with 2µg/mL chalcone. Scale bar 500 x 500 µm (represent entire image)
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While the average normal intercellular stresses both increased and decreased under chalcone treat-
ments, the maximum shear intercellular stresses decreased under both chalcone concentrations
when compared to control conditions. Thirty minutes prior to chalcone treatment, maximum shear
intercellular stresses were also tensile and fluctuated around 230 ± 60 Pa for control, low chalcone
treated, and high chalcone treated HUVECs (figure 3.4a, d and g). After two hours, maximum
shear intercellular stresses generated by endothelial cells exposed to a low dose chalcone and high
dose chalcone treatment fluctuated around 227± 20 Pa (figure 3.4e) and 91 ± 6 Pa (figure 3.4h)
relative to control conditions, which were around 270 ± 30 Pa (figure 3.4b), respectively. At 6
hours, maximum shear intercellular stresses generated by cells exposed to a low dose chalcone
concentration were around 185 ± 10 Pa (figure 3.4f) and 156 ± 30 Pa for cells exposed to a high
dose chalcone concentration (figure 3.4i).
26
Figure 3.4: Maximum shear intercellular stresses (Pa) of HUVEC monolayers during Cx43 inhibi-
tion. Figure labels show maximum shear intercellular stresses of HUVECs at 30 mins (a), 2 hours
(b) and 6 hours (c) of control HUVECs and at 30 mins (d), 2 hours (e) and 6 hours (f) of HUVECs
treated with 0.2µg/mL chalcone and at 30 mins (g), 2 hours (h) and 6 hours (i) of HUVECs treated
with 2µg/mL chalcone. Scale bar 500 x 500 µm (represent entire image)
Maximum shear intercellular stresses generated by control monolayers fluctuated around 241 ± 30
Pa (figure 3.4c).
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Figure 3.5: Comparison of average normal intercellular stress(Pa) (a) and maximum shear inter-
cellular stress(Pa) (b) of HUVEC monolayers in both chalcone treated (0.2 µg/mL and 2 µg/mL)
and control conditions. Error bars showing standard error
On average, we observed a 17% and 6% increase in magnitude of average normal intercellular
stresses with low chalcone treatment and a 55% and 40% decrease in magnitude of average normal
intercellular stresses with high chalcone treatment when compared to control after 2 hours and
6 hours of experiment (figure 3.5a), respectively. At the same time, shear intercellular stresses
decreased by 16% and 23% at low chalcone concentration and decreased by 66% and 35% at high
chalcone concentration when compared to control after 2 hours and 6 hours of experiment (figure
3.5b), respectively. In addition, a rugged intercellular stress landscape was observed for both
normal (supplementary figure 3.10) and shear (supplementary figure 3.11) intercellular stresses at
before chalcone (supplementary figure 3.10 and 3.11a, d and g) and after 2 hours (supplementary
figure 3.10 and 3.11b, e and h) and after 6 hours of experiment (supplementary figure 3.10 and
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3.11c, f and i) and stresses also remained largely tensile in nature.
Cx43 Disruption Reduces RMS Tractions and Strain Energy
Figure 3.6: rms traction (Pa) distributions of HUVEC monolayers during Cx43 disruption. Figure
label shows control HUVECs (a, b and c), 0.2 µg/mL chalcone treated HUVECs (d, e and f) and 2
µg/mL chalcone treated HUVECS (g, h and i) at before any chalcone treatment (labels a, d and g),
after 2 hours of experiment onset (labels b, e and h) and after 6 hours of experiment onset (labels
c, f and i). Scale bar 500 x 500 µm (represent entire image)
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Prior to chalcone treatment (at 30 mins) root mean squared (rms) tractions for all chalcone treat-
ment conditions fluctuated around 59 ± 11 Pa (figure 3.6a, d and g) and after 1 hour of chalcone
treatment rms tractions fluctuated around 51 ± 8 Pa for low dose chalcone (figure 3.6e) and 18 ± 2
Pa for high dose chalcone (figure 3.6h) and 45 ± 9 Pa for control conditions (figure 3.6b). After 6
hours, rms tractions fluctuated around 50 ± 4 Pa for 0.2µg/mL chalcone treated (figure 3.6f), 20 ±
3 Pa for 2µg/mL chalcone treated (figure 3.6i) and 46 ± 5 Pa for control conditions (figure 3.6c),
respectively. This revealed a slight increase of rms tractions at low chalcone dose while high chal-
cone dose yielded an almost 2-fold decrease in rms tractions when compared to control conditions
(figure 3.7a) after 6 hours of experiment.
Figure 3.7: rms tractions (Pa) (a) and strain energy (pJ) (b) in a HUVEC monolayer of both chal-
cone treated (0.2 µg/mL and 2 µg/mL) and control conditions. Error bars showing standard error
In addition, Cx43 disruption decreased strain energy at both chalcone treatment concentrations.
Strain energy magnitude was observed to be 28 ± 3 pJ (figure 3.7b) and cellular velocities were
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around 0.29 ± 0.004 µm/min (figure 3.8a, d and g) at about 30 mins of experiment onset. However,
after 1 hour of chalcone treatment the strain energy decreased to 19 ± 2 pJ and 4 ± 1 pJ for low and
high dose chalcone treatment, respectively. In addition, strain energy plateaued at 3 hours for the
remaining period of the experiment (figure 3.7b).
Cx43 Disruption Reduces Cell Velocities
Figure 3.8: Velocity in HUVEC monolayers during Cx43 inhibition. Figure labels are as fol-
lows—control (a, b and c), 0.2 µg/mL chalcone treated HUVECs (d, e and f) and 2µg/mL chalcone
treated HUVECs (g, h and i) are showing velocity distributions at before chalcone treatment (labels
a, d and g), after an hour of chalcone treatment (labels b, e and h) and at the end of experiment
(labels c, f and i)
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After an hour of chalcone treatment cell velocities were 0.25 ± 0.003 µm/min for 0.2µg/mL chal-
cone treatment (figure 3.8e), 0.20 ± 0.005 µm/min for 2µg/mL chalcone treatment (figure 3.8h) and
0.31 ± 0.002 µm/min under control conditions (figure 3.8b). After 6 hours, cell velocities fluctuated
around 0.27 ± 0.001 µm/min for 0.2µg/mL chalcone treatment (figure 3.8f), 0.17 ± 0.002 µm/min
for 2µg/mL chalcone treatment (figure 3.8i) and 0.21 ± 0.003 µm/min for control conditions (figure
3.8c), respectively.
Figure 3.9: Cellular velocity (µm/min) in a HUVEC monolayer of both chalcone treated (0.2
µg/mL and 2 µg/mL) and control conditions. Error bars showing standard error
While we observed around a 19% and 35% decrease in cell velocities after an hour of treatment for
low and high chalcone dose respectively, after 6 hours of experiment low dose treated monolayers
exhibited 22% increase in cell velocities compared to control (figure 3.9).
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Discussion
In this paper, we report here for the first time how endothelial mechanics are influenced by the gap
junction Cx43. We believe these findings will have implications into many Cx43-related biome-
chanical cellular processes. For example, during in vitro cell migration Cx43 expression was found
to increase and contribute to the movement of the endothelial sheet as a collective via increased
cell-cell coupling [6]. In our experiments we observed that endothelial monolayers exposed to a
high concentration of chalcone decreased cell velocities significantly. In addition, Cx43 has also
been suggested to be essential to endothelial barrier function in addition to tight junctions and
adherens junctions [29] [28]. Here, we report a notable reduction in strain energy as well as a sig-
nificant decrease in maximum shear intercellular stresses and average normal intercellular stresses
generated by the endothelial monolayer in the presence of chalcone. Taken together, our results
suggest to us that endothelial monolayer mechanical strength and/or endothelial barrier function
could be potentially enhanced or diminished by targeting Cx43 communication and expression.
Our results also reveal a surprising increase in normal intercellular stresses and rms tractions com-
pared to control conditions with a low dose of chalcone treatment. While the reason for this
increase is unknown, it is possible that this low dose of chalcone treatment had a brief transient
effect on endothelial mechanics. In addition, previous reports have suggested Cx43 to work in
concert with other gap junctions (Cx40 or Cx37)[31] [34]. Therefore, it is possible that additional
endothelial gap junctions may be compensating for the perturbed Cx43 expression and function
we have observed in this study.
33
Conclusion
The importance of Cx43 in vasculature research is undeniable and has been a research interest for
long time. There have been a host of recent reports showing direct effect of Cx43 on vascular
physiology and pathology [31] [6]. However, to our best knowledge, there have been no reports
relating endothelial mechanics, specifically intercellular stresses with Cx43. As we probe this
complex interplay between Cx43 and endothelial stress generation, we believe our results will pro-
vide insights into how Cx43 communication influences endothelial permeability, barrier strength
as well as leading to a greater understanding of overall endothelial mechanics.
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Supplementary Figures
Figure 3.10: 3D representation of Average Normal Intercellular Stress (Pa) distribution of HUVEC
monolayers. Figure labels are as follows—average normal intercellular stresses of control (a, b and
c), 0.2µg/mL chalcone treatment conditions (d, e and f) and 2µg/mL chalcone treatment condition
(g, h and i) are shown at before chalcone treatment (labels a, d and g), after an hour of chalcone
treatment (labels b, e and h) and at the end of experiment (labels c, f and i).
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Figure 3.11: 3D representation of maximum shear Intercellular Stress (Pa) distribution of HUVEC
monolayer. Figure labels are as follows—maximum shear intercellular stresses of control (a, b and
c), 0.2µg/mL chalcone treatment conditions (d, e and f) and 2µg/mL chalcone treatment condition
(g, h and i) are shown at before 30 chalcone treatment (at 30minutes, labels a, d and g), after
chalcone treatment (at 2 hours, labels b, e and h) and at the end of experiment (at 6 hours, labels c,
f and i).
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Figure 3.12: F-actin staining of HUVEC monolayers at control (a) and chalcone treatment con-
ditions of 0.2 µg/mL (b) and 2 µg/mL (c) after 6 hours of experiment. Scale bar 200 x 200 µm
represent entire image
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CHAPTER 4: MANIPULATING ENDOTHELIUM BIOMECHANICS
THROUGH GAP JUNCTION CX43 ENHANCEMENT
Motivation
Gap junction Cx43 has been intimately linked with vascular wellness as well as vascular illness
[38] [39]. There have been conflicting reports of Cx43 expression improving vascular health as
well as contributing to pathophysiology of vascular diseases. For example, local Cx43 upregu-
lation within the vasculature has been shown to improve monocyte-endothelial adhesion, an im-
portant event linked with the progression of atherosclerosis [40] while other report suggests Cx43
expression to be downregulated in the disturbed flow region where atherosclerotic plaques thrive
in mammals [59]. Similarly, both Cx43 upregulation and downregulation has been reported to
be found in hypertensive rats by several groups [60] [61] [62][63]. Both Cx43 upregulation and
downregulation has been shown to elevate endothelium into pathological states as well as boost en-
dothelium tone in confounding reports [60] [61] [62] [63] [64] [65] [66] [67] [68]. These discrep-
ancies underline the dire need for additional studies and novel approaches to probe endothelium
gap junction Cx43. While most studies probe the change in biochemical responses of endothelium
due to change in gap junction Cx43 expression, endothelial biomechanical response during Cx43
upregulation or downregulation is poorly understood.
In chapter 3, we reported that downregulation of Cx43 expression to increase and decrease average
normal intercellular stress at low dose chalcone treatment and at high dose chalcone treatment,
respectively. At the same time, we observed that rms tractions to be slightly increased during low
dose chalcone treatment and decreased by almost two-fold during high dose chalcone treatment
compared to control. However, impact of gap junction Cx43 upregulation on endothelial biome-
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chanical response such as tractions and intercellular stress generation is yet to understand properly.
To fulfill this purpose, we used retinoic acid to increase HUVEC gap junction Cx43 expression in
a dose-dependent manner. Retinoic acid (RA) is reported to upregulate Cx43 expression when
exposed for longer period of time (24 hours) at 25µM concentration [40]. Here we incubated HU-
VECs with two doses of RA (2.5 µM and 25 µM) for a period of 24 hours at 37°C and 5% CO2
and then seeded them on a PDMS micropatterned soft PA gels (E = 1.2 kPa) coated with 0.1%
collagen-I to grow them in a monolayer fashion. Cells were then imaged for a total of six hours
in RA free media and at this time tractions and intercellular stresses were calculated using traction
force microscopy (TFM) and monolayer stress microscopy (MSM), respectively. Our results reveal
that both low dose (2.5 µM)and high dose (25 µM) RA treatment reduced tractions by 37% and
31% and average normal intercellular stresses by 62% and 48%, respectively, compared to control.
Results
Cx43 Upregulation Reduces Intercellular Stresses
Analysis of all results were performed over a cropped 500 x 500 µm section within the middle of the
1.25 mm micropatterned monolayer. Phase contrast images of control and RA treated conditions
30 minutes before RA treatment and after RA treatment (2 hours and 6 hours) are shown in figure
4.1.
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Figure 4.1: Phase contrast images of HUVEC monolayers after Cx43 upregulation. Control phase
contrast images of HUVECs at 30 mins (a), 2 hours (b) and 6 hours (c). Phase contrast images of
HUVECs treated with 2.5 µM RA at 30 mins (d), 2 hours (e) and 6 hours (f). Phase contrast images
of HUVECs treated with 25 µM RA at 30 mins (g), 2 hours (h) and 6 hours (i). Scale (represent
entire image) is 500 x 500 µm
Thirty minutes prior to RA treatment, average normal intercellular stresses were largely tensile
and fluctuated around 100.5 ± 40 Pa for control, low dose RA treated, and high dose RA treated
HUVECs (figure 4.2a, d and g). Two hours after RA treatment average normal intercellular stresses
were around 50 ± 2 Pa and 68 ± 4 Pa at low dose treatment (figure 4.2e) and high dose treatment
(figure 4.2h) conditions, while control monolayers were around 139 ± 2 Pa (figure 4.2b). After 6
hours, average normal intercellular stresses were observed to be around 49 ± 2 Pa, 63 ± 3 Pa, and
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136 ± 2 Pa for 2.5 µM chalcone treated monolayers (figure 4.2f), 25 µM RA treated monolayers
(figure 4.2i), and control monolayers (figure 4.2c), respectively.
Figure 4.2: Average normal intercellular stresses (Pa) of HUVEC monolayers during Cx43 up-
regulation. Figure labels show average normal intercellular stresses of HUVECs at 30 mins (a),
2 hours (b) and 6 hours (c) of control HUVECs and at 30 mins (d), 2 hours (e) and 6 hours (f)
of HUVECs treated with 2.5µM RA and at 30 mins (g), 2 hours (h) and 6 hours (i) of HUVECs
treated with 25µM RA. Scale bar (represent entire image) is 500 x 500 µm
Likewise average normal intercellular stresses, maximum shear intercellular stresses also decreased
under both RA treatment concentrations when compared to control conditions. Thirty minutes
prior to RA treatment, maximum shear intercellular stresses were also tensile and fluctuated around
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109 ± 17 Pa for control, low dose RA treated, and high dose RA treated HUVECs (figure 4.3a, d
and g). After two hours, maximum shear intercellular stresses generated by endothelial cells ex-
posed to a low dose RA and high dose RA treatment fluctuated around 84± 6 Pa (figure 4.3e) and
102 ± 3 Pa (figure 4.3h) relative to control conditions, which were around 122 ± 3 Pa (figure 4.3b),
respectively.
Figure 4.3: Maximum shear intercellular stresses (Pa) of HUVEC monolayers during Cx43 up-
regulation. Figure labels show maximum shear intercellular stresses of HUVECs at 30 mins (a),
2 hours (b) and 6 hours (c) of control HUVECs and at 30 mins (d), 2 hours (e) and 6 hours (f)
of HUVECs treated with 2.5 µM RA and at 30 mins (g), 2 hours (h) and 6 hours (i) of HUVECs
treated with 25 µM RA. Scale bar (represent entire image) is 500 x 500 µm
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At 6 hours, maximum shear intercellular stresses generated by cells exposed to a low dose RA
concentration were around 79 ± 2 Pa (figure 4.3f) and 90 ± 3 Pa for cells exposed to a high dose
RA concentration (figure 4.3i), while maximum shear intercellular stresses generated by control
monolayers fluctuated around 119 ± 2 Pa (figure 4.3c).
Figure 4.4: Comparison of average normal intercellular stress(Pa) and maximum shear intercellular
stress(Pa) of HUVEC monolayers in both RA treated (2.5 µM and 25 µM) and control conditions.
Error bars showing standard error
On average, we observed 62% and 64% decrease in magnitude of average normal intercellular
stresses with low RA treatment and 51% and 54% decrease in magnitude of average normal in-
tercellular stresses with high RA treatment when compared to control after 2 hours and 6 hours
of experiment (figure 4.4), respectively. At the same time, maximum shear intercellular stresses
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decreased by 31% and 34% at low RA concentration and decreased by 16% and 24% at high
RA concentration when compared to control after 2 hours and 6 hours of experiment (figure 4.4),
respectively.
Cx43 Upregulation Reduces RMS Tractions and Strain Energy
Figure 4.5: rms traction (Pa) distributions of HUVEC monolayers during Cx43 Upregulation.
Figure label shows control HUVECs (a, b and c), 2.5 µM RA treated HUVECs (d, e and f) and 25
µM RA treated treated HUVECS (g, h and i) at before any RA treatment (labels a, d and g), after 2
hours of experiment onset (labels b, e and h) and after 6 hours of experiment onset (labels c, f and
i). Scale bar (represent entire image) is 500 x 500 µm
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Prior to RA treatment (at 30 mins) root mean squared (rms) tractions for all conditions fluctuated
around 16 ± 6 Pa (figure 4.5a, d and g) and after 1 hour of RA treatment rms tractions fluctuated
around 12 ± 2 Pa for low dose RA treatment (figure 4.5e) and 14 ± 2 Pa for high dose RA treatment
(figure 4.5h) and 22 ± 2 Pa for control conditions (figure 4.5b). After 6 hours, rms tractions
fluctuated around 10 ± 2 Pa for 2.5 µM RA treatment (figure 4.5f), 13 ± 3 Pa for 25 µM RA
treatment (figure 4.5i) and 21 ± 1 Pa for control conditions (figure 4.5c), respectively. This revealed
a 38% decrease of rms tractions at high dose RA treatment while low dose RA treatment yielded
an almost 2-fold decrease in rms tractions when compared to control conditions (figure 4.6) after
6 hours of experiment.
Figure 4.6: rms tractions (Pa) and strain energy (pJ) in a HUVEC monolayer of both RA treated
(2.5 µM and 25 µM) and control conditions. Error bars showing standard error
In addition, Cx43 upregulation decreased strain energy and cell velocities at both RA treatment
concentrations. Strain energy on average was observed to be decreased by 69% and 55% in both
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low and high dose RA treatment conditions compared to control conditions (figure 4.6) at 6 hours
of experiment onset. Cell velocities were also observed to be decreased by 70% and 35% in low
dose RA and high dose RA treatment compared to control conditions (figure 4.7) at 6 hours of
experiment onset.
Figure 4.7: Cellular velocity (µm/min) in a HUVEC monolayer of both RA treated (2.5 µM and 25
µM) and control conditions. Error bars showing standard error
Summary
In Summary, Cx43 upregulation by RA treatment at both doses reduced rms tractions, intercellular
stresses, strain energy and cell velocities in HUVEC monolayers compared to control conditions.
Surprisingly, the decrease in tractions and intercellular stresses found to be more drastic in low
dose RA treated HUVEC monolayers compared to the high dose RA treated monolayers. While
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low doses show a dramatic decrease, high doses show higher tractions and intercellular stresses
compared to low dose RA treatment. The results we present here may explain why Cx43 upregu-
lation has been adversely linked with the progression of hypertension in rats [60][61].
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CHAPTER 5: INFLUENCE OF FLUID SHEAR STRESS ON
ENDOTHELIUM BIOMECHANICS
Motivation
Thus far, we have observed that Cx43 downregulation by high dose chalcone and Cx43 upregula-
tion by high dose RA decreased endothelial tractions and intercellular stresses compared to their
respective control conditions. In addition, Cx43 downregulation by low dose chalcone yielded
a higher tractions and intercellular stresses while Cx43 upregulation by low dose RA treatment
yielded a decreased tractions and intercellular stresses in HUVECs compared to control. However,
these experiments were performed in petri dish or in static conditions. We know that ECs con-
stantly exposed to biomechanical cues such as blood induced fluid shear stress and cyclic stretch
[1] [2]. However, among all the biomechanical factors experienced by endothelial cells, fluid shear
stress is documented to be critically important [2] [5] [4]. While we observed the influence of
biochemical factors (chalcone or RA) on EC mechanics, at the same time how biomechanical fac-
tor such as blood-induced fluid shear stress influences EC biomechanics is not known. Therefore,
the objective of this study is to introduce fluid shear stress on adherent micropatterned HUVEC
monolayers while either disrupting or enhancing gap junction Cx43 expression using two doses of
chalcone or retinoic acid, respectively. To acheive this goal, we introduced unidirectional laminar
fluid shear stress of magnitude 1 Pa on micropatterned endothelial cells attached on a 0.1 mg/mL
collagen-I coated PA gel of stiffness 1.2 Kpa. The gels were polymerized on a microscopic slide
and to introduce fluid shear stress, we used a sticky luer ibidi flow chamber attached to the slide.
At the same time, endothelial gap junction Cx43 were downregulated by chalcone with two doses
(0.83 µM and 8.3 µM) and upregulated with RA in dose dependent manner (2.5 µM and 25 µM)
in separate experiments. At this time, tractions and intercellular stresses were calculated using
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traction force microscopy and monolayer stress microscopy, respectively.
Experimental Design to Exert Fluid Shear Stress
Experimental setup of fluid shear flow is described in the figure 5.1 below. Briefly, PA gels were
polymerized on a microscopic slide and then functionalized using Sulfo-SANPAH under UV light
for 8 mins. After washing off excess SANPAH, microscopic slides were micropatterned with
PDMS stamps and treated with collagen-I for overnight in the refrigerator at 4°C. In the following
day, HUVECs were detached using 1x trypsin and seeded onto the micropatterned gel for an hour
at 37°C and 5% CO2 in the incubator. After that PDMS patterns were removed and EC monolayers
were allowed to grow into confluence for additional 36 hours at 37°C and 5% CO2 in the incubator.
Then, slides were attached to a sticky ibidi flow chamber of known dimension. Volumetric flow
rate was calculated to be 7.1 ml/min to exert a unidirectional laminar fluid shear stress of magnitude
1 Pa on cultured EC with the help of a peristaltic pump. Using a connected circuit of pump and
media reservoir, this flow rate was achieved and an inverted microscope was used to take images
of the EC monolayer.
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Figure 5.1: Experimental design to exert fluid shear stress on micropatterned HUVECs. (a)
schematic setup of exerting fluid shear stress on cultured cells attached to a PA gel on a micro-
scopic slide (b) formulation to calculate fluid shear stress.
Fluid Shear Stress and Cx43 Downregulation Impacts Endothelial Biomechanics
Analysis of all results was performed over a cropped 500 x 500 µm section within the middle
of the 1.25 mm micropatterned monolayer. Phase contrast images of control and chalcone treated
conditions 30 minutes before chalcone treatment and after chalcone treatment (2 hours and 6 hours)
are shown in figure 5.2.
50
Figure 5.2: Phase contrast images of HUVEC monolayers after Cx43 disruption under fluid shear
flow. Control phase contrast images of HUVECs at 30 mins (a), 2 hours (b) and 6 hours (c). Phase
contrast images of HUVECs treated with 0.83 µM chalcone at 30 mins (d), 2 hours (e) and 6 hours
(f). Phase contrast images of HUVECs treated with 8.3 µM chalcone at 30 mins (g), 2 hours (h)
and 6 hours (i). Scale bar (represents entire image) 500 x 500 µm
Thirty minutes prior to chalcone treatment, average normal intercellular stresses were largely ten-
sile and fluctuated around 156 ± 21 Pa for control, low dose chalcone treated, and high dose chal-
cone treated HUVECs (figure 5.3a, d and g). Two hours after chalcone treatment average normal
intercellular stresses were around 227 ± 4 Pa and 72 ± 9 Pa at low chalcone treatment (figure 5.3e)
and high chalcone treatment (figure 5.3h) conditions, while control monolayers were around 210
± 6 Pa (figure 3b). After 6 hours, average normal intercellular stresses were observed to be around
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210 ± 2 Pa, 50 ± 3 Pa, and 148 ± 2 Pa for 0.83 µM chalcone treated monolayers (figure 5.3f), 8.3
µM chalcone treated monolayers (figure 5.3i), and control monolayers (figure 5.3c), respectively.
Figure 5.3: Average normal intercellular stresses (Pa) of HUVEC monolayers during Cx43 inhibi-
tion under fluid shear flow. Figure labels show average normal intercellular stresses of HUVECs
at 30 mins (a), 2 hours (b) and 6 hours (c) of control HUVECs and at 30 mins (d), 2 hours (e) and
6 hours (f) of HUVECs treated with 0.83 µM chalcone and at 30 mins (g), 2 hours (h) and 6 hours
(i) of HUVECs treated with 8.3 µM chalcone. Scale bar (represents entire image) 500 x 500 µm
Like the average normal intercellular stresses, the maximum shear intercellular stresses increased
and decreased under both chalcone concentrations when compared to control conditions. Thirty
minutes prior to chalcone treatment, maximum shear intercellular stresses were also tensile and
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fluctuated around 142 ± 3 Pa for control, low chalcone treated, and high chalcone treated HUVECs
(figure 5.4a, d and g). After two hours, maximum shear intercellular stresses generated by endothe-
lial cells exposed to a low dose chalcone and high dose chalcone treatment fluctuated around 175±
20 Pa (figure 5.4e) and 78 ± 10 Pa (figure 5.4h) relative to control conditions, which were around
138 ± 8 Pa (figure 5.4b), respectively. At 6 hours, maximum shear intercellular stresses generated
by cells exposed to a low dose chalcone concentration were around 119 ± 6 Pa (figure 5.4f) and
67 ± 3 Pa for cells exposed to a high dose chalcone concentration (figure 5.4i). Maximum shear
intercellular stresses generated by control monolayers fluctuated around 113 ± 3 Pa (figure 5.4c).
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Figure 5.4: Maximum shear intercellular stresses (Pa) of HUVEC monolayers during Cx43 inhibi-
tion under fluid shear stress. Figure labels show maximum shear intercellular stresses of HUVECs
at 30 mins (a), 2 hours (b) and 6 hours (c) of control HUVECs and at 30 mins (d), 2 hours (e) and
6 hours (f) of HUVECs treated with 0.83 µM chalcone and at 30 mins (g), 2 hours (h) and 6 hours
(i) of HUVECs treated with 8.3 µM chalcone. Scale bar (represents entire image) 500 x 500 µm
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Figure 5.5: Comparison of average normal intercellular stress(Pa) and maximum shear intercellular
stress(Pa) of HUVEC monolayers in both chalcone treated (0.83 µM and 8.3 µM) and control
conditions under fluid shear flow. Error bars showing standard error
On average, we observed a 7.5% and 30% increase in magnitude of average normal intercellular
stresses with low chalcone treatment and 65% and 66% decrease in magnitude of average normal
intercellular stresses with high chalcone treatment when compared to control after 2 hours and
6 hours of experiment (figure 5.5a), respectively. At the same time, shear intercellular stresses
increased by 21% and 5% at low chalcone concentration and decreased by 43% and 41% at high
chalcone concentration when compared to control after 2 hours and 6 hours of experiment (figure
5.5b), respectively.
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Figure 5.6: rms traction (Pa) distributions of HUVEC monolayers during Cx43 disruption under
fluid shear flow. Figure label shows control HUVECs (a, b and c), 0.83 µM chalcone treated
HUVECs (d, e and f) and 8.3 µM chalcone treated HUVECs (g, h and i) at before any chalcone
treatment (labels a, d and g), after 2 hours of experiment onset (labels b, e and h) and after 6 hours
of experiment onset (labels c, f and i). Scale bar (represents entire image) 500 x 500 µm
Prior to chalcone treatment (at 30 mins) root mean squared (rms) tractions for all chalcone treat-
ment conditions fluctuated around 25 ± 8 Pa (figure 5.6a, d and g) and after 1 hour of chalcone
treatment rms tractions fluctuated around 34 ± 4 Pa for low dose chalcone (figure 5.6e) and 18 ±
2 Pa for high dose chalcone (figure 5.6h) and 30 ± 4 Pa for control conditions (figure 5.6b). After
6 hours, rms tractions fluctuated around 25 ± 2 Pa for 0.83 µM chalcone treated (figure 5.6f), 12
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± 3 Pa for 8.3 µM chalcone treated (figure 5.6i) and 22 ± 2 Pa for control conditions (figure 5.6c),
respectively. This revealed a slight increase of rms tractions at low chalcone dose while high chal-
cone dose yielded 45% decrease in rms tractions when compared to control conditions (figure 5.7)
after 6 hours of experiment.
Figure 5.7: rms tractions (Pa) and strain energy (pJ) in a HUVEC monolayer of both chalcone
treated (0.83 µM and 8.3 µM) and control conditions under fluid shear flow. Error bars showing
standard error
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Figure 5.8: Cellular velocity (µm/min) in a HUVEC monolayer of both chalcone treated (0.83 µM
and 8.3 µM) and control conditions under fluid shear flow. Error bars showing standard error
In addition, Cx43 disruption increased and decreased strain energy and cell velocities at low and
high chalcone treatment concentrations, respectively, compared to control conditions. Strain en-
ergy magnitude was increased on average 20% and 70% for low and high dose chalcone concen-
tration compared to control (figure 5.7). On the other hand, Cell velocities on average increased
40% and decreased 51% at low and high dose chalcone compared to control (figure 5.8).
Fluid Shear Stress and Cx43 Upregulation Impacts Endothelial Biomechanics
Analysis of all results was performed over a cropped 500 x 500 µm section within the middle of the
1.25 mm micropatterned monolayer. Phase contrast images of control and RA treated conditions
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30 minutes before RA treatment and after RA treatment (2 hours and 6 hours) are shown in figure
5.9.
Figure 5.9: Phase contrast images of HUVEC monolayers after Cx43 upregulation in shear exp.
Control phase contrast images of HUVECs at 30 mins (a), 2 hours (b) and 6 hours (c). Phase
contrast images of HUVECs treated with 2.5 µM RA at 30 mins (d), 2 hours (e) and 6 hours (f).
Phase contrast images of HUVECs treated with 25 µM RA at 30 mins (g), 2 hours (h) and 6 hours
(i). Scale bar (represents entire image) 500 x 500 µm
Thirty minutes prior to RA treatment, average normal intercellular stresses were largely tensile and
fluctuated around 188 ± 60 Pa for control, low dose RA treated, and high dose RA treated HUVECs
(figure 5.10a, d and g). Two hours after RA treatment average normal intercellular stresses were
around 124 ± 3 Pa and 190 ± 6 Pa at low dose treatment (figure 5.10e) and high dose treatment
59
(figure 5.10h) conditions, while control monolayers were around 247 ± 2 Pa (figure 5.10b). After 6
hours, average normal intercellular stresses were observed to be around 130 ± 2 Pa, 187 ± 3 Pa, and
263 ± 2 Pa for 2.5 µM chalcone treated monolayers (figure 5.10f), 25 µM RA treated monolayers
(figure 5.10i), and control monolayers (figure 5.10c), respectively.
Figure 5.10: Average normal intercellular stresses (Pa) of HUVEC monolayers during Cx43 up-
regulation under fluid shear stress. Figure labels show average normal intercellular stresses of
HUVECs at 30 mins (a), 2 hours (b) and 6 hours (c) of control HUVECs and at 30 mins (d), 2
hours (e) and 6 hours (f) of HUVECs treated with 2.5µM RA and at 30 mins (g), 2 hours (h) and 6
hours (i) of HUVECs treated with 25µM RA. Scale bar (represents entire image) 500 x 500 µm
Likewise average normal intercellular stresses, maximum shear intercellular stresses also decreased
under both RA treatment concentrations when compared to control conditions. Thirty minutes
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prior to RA treatment, maximum shear intercellular stresses were also tensile and fluctuated around
128 ± 35 Pa for control, low dose RA treated, and high dose RA treated HUVECs (figure 5.11a,
d and g). After two hours, maximum shear intercellular stresses generated by endothelial cells
exposed to a low dose RA and high dose RA treatment fluctuated around 90 ± 10 Pa (figure 5.11e)
and 115 ± 4 Pa (figure 5.11h) relative to control conditions, which were around 158 ± 6 Pa (figure
5.11b), respectively.
Figure 5.11: Maximum shear intercellular stresses (Pa) of HUVEC monolayers during Cx43 up-
regulation under fluid shear stress. Figure labels show maximum shear intercellular stresses of
HUVECs at 30 mins (a), 2 hours (b) and 6 hours (c) of control HUVECs and at 30 mins (d), 2
hours (e) and 6 hours (f) of HUVECs treated with 2.5 µM RA and at 30 mins (g), 2 hours (h) and
6 hours (i) of HUVECs treated with 25 µM RA. Scale bar (represents entire image) 500 x 500 µm
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At 6 hours, maximum shear intercellular stresses generated by cells exposed to a low dose RA
concentration were around 88 ± 2 Pa (figure 5.11f) and 104 ± 3 Pa for cells exposed to a high dose
RA concentration (figure 5.11i), while maximum shear intercellular stresses generated by control
monolayers fluctuated around 161 ± 2 Pa (figure 5.11c).
Figure 5.12: Comparison of average normal intercellular stress(Pa) and maximum shear inter-
cellular stress(Pa) of HUVEC monolayers in both RA treated (2.5 µM and 25 µM) and control
conditions under fluid shear stress. Error bars showing standard error
On average, we observed a 50% and 51% decrease in magnitude of average normal intercellular
stresses with low RA treatment and a 23% and 29% decrease in magnitude of average normal
intercellular stresses with high RA treatment when compared to control after 2 hours and 6 hours
of experiment (figure 5.12), respectively. At the same time, maximum shear intercellular stresses
decreased by 43% and 27% at low RA concentration and decreased by 45% and 35% at high RA
concentration when compared to control after 2 hours and 6 hours of experiment (figure 5.12),
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respectively.
Figure 5.13: rms traction (Pa) distributions of HUVEC monolayers during Cx43 Upregulation
under fluid shear stress. Figure label shows control HUVECs (a, b and c), 2.5 µM RA treated
HUVECs (d, e and f) and 25 µM RA treated treated HUVECs (g, h and i) at before any RA
treatment (labels a, d and g), after 2 hours of experiment onset (labels b, e and h) and after 6 hours
of experiment onset (labels c, f and i). Scale bar (represents entire image) 500 x 500 µm
Prior to RA treatment (at 30 mins) root mean squared (rms) tractions for all conditions fluctuated
around 18 ± 5 Pa (figure 5.13a, d and g) and after 1 hour of RA treatment rms tractions fluctuated
around 14 ± 2 Pa for low dose RA treatment (figure 5.13e) and 19 ± 2 Pa for high dose RA
treatment (figure 5.13h) and 21 ± 2 Pa for control conditions (figure 5.13b). After 6 hours, rms
tractions fluctuated around 13 ± 2 Pa for 2.5 µM RA treatment (figure 5.13f), 17 ± 3 Pa for 25 µM
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RA treatment (figure 5.13i) and 20 ± 1 Pa for control conditions (figure 5.13c), respectively. This
revealed a 15% decrease of rms tractions at high dose RA treatment while low dose RA treatment
yielded 35% decrease in rms tractions when compared to control conditions (figure 5.14) after 6
hours of experiment.
Figure 5.14: rms tractions (Pa) and strain energy (pJ) in a HUVEC monolayer of both RA treated
(2.5 µM and 25 µM) and control conditions under fluid shear stress. Error bars showing standard
error
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Figure 5.15: Cellular velocity (µm/min) in a HUVEC monolayer of both RA treated (2.5 µM and
25 µM) and control conditions under fluid shear stress. Error bars showing standard error
In addition, Cx43 upregulation under shear flow decreased strain energy and cell velocities at both
RA treatment concentrations. Strain energy on average was observed to be decreased by 55% and
37% in both low and high dose RA treatment conditions compared to control conditions after 6
hours of experiment (figure 5.14). Cell velocities were also observed to be decreased by 51% and
35% in low dose RA and high dose RA treatment conditions, respectively, compared to control
conditions after 6 hours of experiment (figure 5.15).
Summary
Here, we observed that under the influence of fluid shear stress, rms tractions and intercellular
stresses, strain energy and cell velocities were decreased by both low dose RA treatment and high
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dose RA treatment compared to control conditions. Like static control experiments, both RA treat-
ment yielded decreased tractions and intercellular stresses compared to control conditions under
laminar fluid shear stress. It is notable that, whether in static or fluid shear stress experiments, low
dose RA treatment yielded more drastic decrease compared to high dose RA treatment conditions.
Since, both treatment conditions yielded decreased tractions and intercellular stresses in all type of
experiments, Cx43 upregulation appears to be consistently involved in lowering the intercellular
response in endothelium by RA treatment.
Supplementary Section
Western Blotting
HUVECs were cultured in a 6 cm petri dish with media 200 supplemented with LVES and with
1% penicillin streptomycin and grown to confluence. HUVECs were then treated with two doses
of chalcone (0.83 µM and 8.3 µM) for 5 hours and two doses of retinoic acid (2.5 µM and 25 µM)
for 24 hours in the incubator at 37°C and 5% CO2. Control HUVECs were treated with 0.5%
DMSO for 5 hours and 5% DMSO for 24 hours to compare with chalcone treated and retinoic
acid treated HUVECs, respectively, in the incubator. HUVECs were then treated with radioim-
munoprecipitation assay buffer(RIPA buffer) supplemented with protease inhibitor tablets for 20
mins in the incubator at 37°C and 5% CO2. Cells were then scrapped with the help of a cell
scrapper and transferred to a 1.5 mL microcentrifuge tube. Samples were then spun at 10,000
x g for 10 minutes and supernatants were collected into separate 1.5 mL microcentrifuge tubes.
Protein concentrations were then calculated using a Nanodrop assay (BCA Gold-Kit). Prior to
protein separation, samples were denatured at 70°C on a hot plate. Gel electrophoresis assay was
then used to separate the proteins by using Blot 4-12% Bis-Tris Plus gels for 35 minutes. Pro-
teins were then transferred to polyvinylidene fluoride (PVDF) membranes by using a blot transfer
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assay for 7 minutes. Membranes were then left to dry overnight at 25°C. In the following day,
membranes were then rinsed with 10% methanol and then rinsed with PBS and were blocked with
blocking solution for 1 hour at room temperature while being shaken. Blocking solution contained
blocking buffer with 0.2% Tween-20. After removal of blocking buffer solution, membranes were
then treated with mouse monoclonal connexin43 antibody (Cx-1b1) at a dilution of 1:167 and β-
tubulin monoclonal antibody at a dilution of 1:1000 for overnight at 4°C while being shaken. In
the following day, membranes were then rinsed for 5 minutes for 3 consecutive times with PBS-T
(0.2% Tween-20) solution and then secondary antibodies (donkey anti-mouse 800 with a dilution
of 1:10000 and donkey anti-rabbit 600 with a dilution of 1:10000) were added for 1 hour at 25°C
while being shaken. Membranes were then rinsed for 5 minutes for 3 consecutive times with PBS
with 0.2% Tween-20 and 0.01% SDS solution. Membranes were then imaged using Licor Odyssey
assay and the optical density for each band was quantified using ImageJ. Supplementary figures
5.16 and 5.17 show the downregulation of Cx43 expression by chalcone and upregulation of Cx43
by retinoic acid compared to control, respectively.
67
Figure 5.16: Western blot analysis of HUVECs treated with low and high doses of chalcone. (a)
Shows the Cx43 expression in different conditions normalized to loading control. (b) Shows the
optical bands obtained using licor assay after western blotting. Error bar showing standard error
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Figure 5.17: Western blot analysis of HUVECs treated with low and high doses of retinoic acid.
(a) Shows the Cx43 expression in different conditions normalized to loading control. (b) Shows




CHAPTER 6: PROBING THE INFLUENCE OF HYPERGLYCEMIA ON
ENDOTHELIUM BIOMECHANICS
Motivation
Although the risk for an adverse cardiovascular event is present for anybody without any prior
sign, endothelial dysfunction appears to be consistent for diabetic patients [44]. In fact, diabetic
patients are more likely to suffer from cardiovascular diseases (CVDs) than normal person and an
alarming number of diabetic patients loss their life from CVDs [44] [45] [46]. Diabetic patient
suffers from host of metabolic conditions and his/her vasculature experiences an excessive amount
of blood sugar. Since, many diverse factors such as hyperglycemia, insulin-resistivity, hyperlipi-
demia, metabolic disorders and obesity can contribute to the development of CVDs in a diabetic
patient, it is difficult to discern the specific role hyperglycemia plays in the progression of CVDs
[44] [46]. Various studies conducted by researchers have supported as well as disputed the contri-
bution of hyperglycemia alone in the progression of CVDs [44]. For example, postmortem studies
of children and young patient with type-I diabetes showed enhanced fatty streaks in the absence
of hyperlipidemia suggesting that hyperglycemia alone may promote early plaque formation [47].
Contrary to this study, hyperglycemia was strongly found to be associated to early plaque develop-
ment in atherosclerosis-prone mice, but the progression of plaques required dyslipidemia [50]. De-
spite conflicting opinions, there is growing evidence to suggest that hyperglycemia independently
may contribute greatly to endothelial dysfunction and subsequently, may lead to life-threatening
vascular complications [44] [46] [47]. Thus far, majority of the scientific reports probed the influ-
ence of hyperglycemia on various biochemical pathways associated with endothelium. However,
very little is known about the influence of hyperglycemia alone on endothelial biomechanical force
generation and transmission. To fill this gap, we cultured HUVECs in high level of glucose (20
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mmol/L of d-glucose), normal glucose condition (5.6 mmol/L of d-glucose) and d-mannitol (5.6
mmol/L d-glucose + 14.4 mmol/L d-mannitol) as osmotic control for 10 consecutive days. After
that, cells were seeded onto PDMS micropatterned soft PA gels coated with 0.1% collagen-I in a
monolayer fashion for 1 hour. After 1 hour, patterns were removed and cells were then allowed
to form a confluent monolayer for additional 24 hours. In the following day, 3 hours time lapse
experiments were performed supplemented with their respective glucose media. Experiments were
repeated under the influence of unidirectional laminar fluid shear stress of magnitude 1 Pa. At this
time, tractions and intercellular stresses were measured using traction force microscopy and mono-
layer stress microscopy, respectively. Taken together, our results represent a unique report of the
influence of hyperglycemia alone on Endothelial mechanics. We believe our results will contribute
greatly to the better understanding of endothelial dysfunction in diabetic patients.
Influence of Different Level of Glucose on Endothelial Biomechanics in Static Control
Experiments
Analysis of all results was performed over a cropped 500 x 500 µm section within the middle of
the 1.25 mm micropatterned monolayer. Phase contrast images of normal glucose, hyperglycemic
and d-mannitol conditions at the beginning (0 hours) and two later times (1 hours and 3 hours) are
shown in figure 6.1.
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Figure 6.1: Phase contrast images of HUVEC monolayers treated with different level of glucose.
phase contrast images of normal glucose treated HUVECs at 0 hour (a), 1 hour (b) and 3 hours (c).
Phase contrast images of HUVECs treated with high level of glucose at 0 hours (d), 1 hour (e) and
3 hours (f). Phase contrast images of HUVECs treated with d-mannitol at 0 hour (g), 1 hour (h)
and 3 hour (i). Scale bar (represents entire image) is 500 x 500 µm
At the beginning, average normal intercellular stresses were largely tensile and fluctuated around
492 ± 90 Pa for all glucose treated conditions (figure 6.2a, d and g). One hour of experiment onset
average normal intercellular stresses were around 525 ± 60 ,454 ± 22 Pa and 417 ± 8 Pa at normal
glucose, high glucose and d-mannitol conditions (figure 6.2 b, e and h). After 3 hours, average
normal intercellular stresses were observed to be around 522 ± 2 Pa, 460 ± 7 Pa, and 385 ± 29 Pa
for normal glucose, high glucose and d-mannitol conditions, respectively (figure 6.2c, f and i).
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Figure 6.2: Average normal intercellular stresses (Pa) of HUVEC monolayers treated with different
level of glucose. Figure labels show average normal intercellular stresses of normal glucose treated
HUVECs at 0 hour (a), 1 hour (b) and 3 (c) hours and HUVECs treated with high level of glucose
at 0 hours (d), 1 hour (e) and 3 hours (f) and HUVECs treated with d-mannitol at 0 hour (g), 1 hour
(h) and 3 hour (i). Scale bar (represents entire image) is 500 x 500 µm
At the beginning, maximum shear intercellular stresses were largely tensile and fluctuated around
250 ± 15 Pa for all glucose treated conditions (figure 6.3a, d and g). One hour of experiment onset
shear intercellular stresses were around 251 ± 3 ,243 ± 2 Pa and 180 ± 4 Pa at normal glucose,
high glucose and d-mannitol conditions (figure 6.3 b, e and h). After 3 hours, average normal
intercellular stresses were observed to be around 231 ± 2 Pa, 187 ± 6 Pa, and 175 ± 2 Pa for normal
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glucose, high glucose and d-mannitol conditions, respectively (figure 6.3 c,f and i).
Figure 6.3: Maximum shear intercellular stresses (Pa) of HUVEC monolayers treated with dif-
ferent level of glucose. Figure labels show shear intercellular stresses of normal glucose treated
HUVECs at 0 hour (a), 1 hour (b) and 3 hours and HUVECs treated with high level of glucose at
0 hours (d), 1 hour (e) and 3 hours (f) and HUVECs treated with d-mannitol at 0 hour (g), 1 hour
(h) and 3 hour (i). Scale bar (represents entire image) is 500 x 500 µm
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Figure 6.4: Comparison of average normal intercellular stress(Pa) and maximum shear intercel-
lular stress(Pa) of HUVEC monolayers different level of glucose conditions. Error bars showing
standard error
On average, we observed a 20% and 12% decrease in magnitude of average normal intercellular
stresses with high glucose treatment and a 27% and 26% decrease in magnitude of average normal
intercellular stresses with d-mannitol treatment when compared to normal glucose at 0 hours and
3 hours of experiment (figure 6.4), respectively. At the same time, maximum shear intercellular
stresses decreased by 3.5% and 19% at high glucose and decreased by 23% and 24% at d-mannitol
compared to normal glucose at 0 hours and 3 hours of experiment (figure 6.4), respectively.
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Figure 6.5: rms traction (Pa) distributions of HUVEC monolayers treated with different level of
glucose. Figure labels show rms tractions of normal glucose treated HUVECs at 0 hour (a), 1 hour
(b) and 3 hours (c) and HUVECs treated with high level of glucose at 0 hours (d), 1 hour (e) and
3 hours (f) and HUVECs treated with d-mannitol at 0 hour (g), 1 hour (h) and 3 hour (i) Scale bar
(represents entire image) is 500 x 500 µm
At the beginning, rms tractions were largely tensile and fluctuated around 82 ± 26 Pa for all glucose
treated conditions (figure 6.5a, d and g). One hour of experiment onset rms tractions were around
86 ± 5 ,69 ± 7 Pa and 57 ± 7 Pa at normal glucose, high glucose and d-mannitol conditions (figure
6.5 b,e and h). After 3 hours, average normal intercellular stresses were observed to be around
88 ± 2 Pa, 67 ± 4 Pa, and 62 ± 3 Pa for normal glucose, high glucose and d-mannitol conditions,
respectively (figure 6.5 c,f, and i). This indicates a 20% and 24% decrease in magnitude of rms
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tractions with high glucose treatment and a 34% and 30% decrease in magnitude of rms tractions
with d-mannitol treatment when compared to normal glucose at 0 hours and 3 hours of experiment
(figure 6.6).
Figure 6.6: rms tractions (Pa) and strain energy (pJ) in a HUVEC monolayer at different level of
glucose conditions. Error bars showing standard error
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Figure 6.7: Cellular velocity (µm/min) in a HUVEC monolayer at different level of glucose cond-
tions. Error bars showing standard error
In addition, we observed a decrease in strain energy and cell velocities at high glucose and d-
mannitol conditions compared to normal glucose conditions. Strain energy on average was ob-
served to be decreased by 22% and 25% in high glucose and d-mannitol treatment conditions
compared to normal glucose conditions (figure 6.6). Cell velocities were also observed to be de-
creased by 15% and 24% in high glucose and d-mannitol treatment conditions compared to normal
glucose conditions (figure 6.7).
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Influence of Different Level of Glucose on Endothelial Biomechanics Under Fluid Shear Flow
Analysis of all results was performed over a cropped 500 x 500 µm section within the middle of
the 1.25 mm micropatterned monolayer. Phase contrast images of normal glucose, hyperglycemic
and d-mannitol conditions under shear flow at the beginning (0 hours) and a later time (1 hours and
3 hours) are shown in figure 6.8.
Figure 6.8: Phase contrast images of HUVEC monolayers treated with different level of glucose
under fluid shear stress. phase contrast images of normal glucose treated HUVECs at 0 hour (a), 1
hour (b) and 3 hours (c). Phase contrast images of HUVECs treated with high level of glucose at
0 hours (d), 1 hour (e) and 3 hours (f). Phase contrast images of HUVECs treated with d-mannitol
at 0 hour (g), 1 hour (h) and 3 hours (i). Scale bar (represents entire image) is 500 x 500 µm
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At the beginning, average normal intercellular stresses were largely tensile and fluctuated around
69 ± 23 Pa for all glucose treated conditions (figure 6.9a, d and g). One hour of experiment onset
average normal intercellular stresses were around 50 ± 6 ,84 ± 8 Pa and 62 ± 6 Pa at normal
glucose, high glucose and d-mannitol conditions (figure 6.9 b,e and h). After 3 hours, average
normal intercellular stresses were observed to be around 40 ± 8 Pa, 81 ± 4 Pa, and 54 ± 2 Pa for
normal glucose, high glucose and d-mannitol conditions, respectively (figure 6.9 e,f, and i).
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Figure 6.9: Average normal intercellular stresses (Pa) of HUVEC monolayers treated with different
level of glucose under fluid shear stress. Figure labels show average normal intercellular stresses
of normal glucose treated HUVECs at 0 hour (a), 1 hour (b) and 3 hours and HUVECs treated
with high level of glucose at 0 hours (d), 1 hour (e) and 3 hours (f) and HUVECs treated with
d-mannitol at 0 hour (g), 1 hour (h) and 3 hour (i). Scale bar (represents entire image) is 500 x 500
µm
At the beginning, maximum shear intercellular stresses were largely tensile and fluctuated around
63 ± 18 Pa for all glucose treated conditions (figure 6.10a, d and g). One hour of experiment
onset shear intercellular stresses were around 48 ± 3 ,84 ± 6 Pa and 59 ± 2 Pa at normal glucose,
high glucose and d-mannitol conditions (figure 6.10 b,e, and h). After 3 hours, average normal
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intercellular stresses were observed to be around 40 ± 2 Pa, 82 ± 2 Pa, and 49 ± 4 Pa for normal
glucose, high glucose and d-mannitol conditions, respectively (figure 6.10 c,f, and i).
Figure 6.10: Maximum shear intercellular stresses (Pa) of HUVEC monolayers treated with dif-
ferent level of glucose under fluid shear stress. Figure labels show shear intercellular stresses of
normal glucose treated HUVECs at 0 hour (a), 1 hour (b) and 3 hours and HUVECs treated with
high level of glucose at 0 hour (d), 1 hour (e) and 3 hours (f) and HUVECs treated with d-mannitol
at 0 hour (g), 1 hour (h) and 3 hour (i). Scale bar (represents entire image) is 500 x 500 µm
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Figure 6.11: Comparison of average normal intercellular stress(Pa) and maximum shear intercellu-
lar stress(Pa) of HUVEC monolayers different level of glucose conditions under fluid shear stress.
Error bars showing standard error
On average, we observed a 40% and 50% increase in magnitude of average normal intercellular
stresses with high glucose treatment and a 19% and 26% increase in magnitude of average normal
intercellular stresses with d-mannitol treatment when compared to normal glucose at 0 hour and
3 hours of experiment (figure 6.11), respectively. At the same time, maximum shear intercellular
stresses decreased by 43% and 51% at high glucose and decreased by 19% and 18% at d-mannitol
compared to normal glucose at 0 hours and 3 hours of experiment (figure 6.11), respectively.
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Figure 6.12: rms traction (Pa) distributions of HUVEC monolayers treated with different level
of glucose under fluid shear stress. Figure labels show rms tractions of normal glucose treated
HUVECs at 0 hour (a), 1 hour (b) and 3 hours and HUVECs treated with high level of glucose at 0
hour (d), 1 hour (e) and 3 hours (f) and HUVECs treated with d-mannitol at 0 hour (g), 1 hour (h)
and 3 hour (i) Scale bar (represents entire image) is 500 x 500 µm
At the beginning, rms tractions were largely tensile and fluctuated around 12 ± 4 Pa for all glucose
treated conditions (figure 6.12a, d and g). One hour of experiment onset rms tractions were around
11 ± 2 ,15 ± 1 Pa and 10 ± 1 Pa at normal glucose, high glucose and d-mannitol conditions (figure
6.12 b,e and h). After 3 hours, average normal intercellular stresses were observed to be around
8 ± 1 Pa, 14 ± 2 Pa, and 9 ± 2 Pa for normal glucose, high glucose and d-mannitol conditions,
respectively (figure 6.12 c,f, and i). This indicates a 3% and 42% increase in magnitude of rms
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tractions with high glucose treatment and 10% and 11% increase in magnitude of rms tractions
with d-mannitol treatment when compared to normal glucose at 0 hour and 3 hours of experiment
(figure 6.13).
Figure 6.13: rms tractions (Pa) and strain energy (pJ) in a HUVEC monolayer at different level of
glucose conditions under fluid shear stress. Error bars showing standard error
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Figure 6.14: Cellular velocity (µm/min) in a HUVEC monolayer at different level of glucose con-
ditions under flud shear stress. Error bars showing standard error
In addition, we observed a decrease in strain energy and cell velocities at high glucose snd d-
mannitol conditions compared to normal glucose conditions. Strain energy on average was ob-
served to be increased by 44% and 13% in high glucose and d-mannitol treatment conditions
compared to normal glucose conditions after 3 hours of experiment (figure 6.13). Cell velocities
were also observed to be increased by 73% and 17% in high glucose and d-mannitol treatment
conditions compared to normal glucose conditions after 3 hours of experiment (figure 6.14).
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Summary
In this chapter, we observed the influence of different level of glucose on EC biomechanics. In
static control experiments, we found that normal glucose yielded the highest rms tractions and
intercellular stresses compared to hyperglycemic and d-mannitol conditions. While the osmotic
control d-mannitol yielded a lower tractions and intercellular stresses compared to normal glucose
condition, hyperglycemia resulted an increase in rms tractions and intercellular stresses compared
to osmotic control conditions in static experiments. On the other hand, under the laminar fluid shear
stress of 1 Pa, we observed a drastic decrease in intercellular stresses in all conditions compared
to static control conditions. Under fluid shear stress, we observed a 11-fold, 5-fold, and 7-fold
decrease in magnitude of average normal intercellular stresses in hyperglycemic, d-mannitol and
normal glucose conditions,respectively, compared to static control experiments.
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CHAPTER 7: DISCUSSION
Impact of Cx43 Downregulation on Endothelium Biomechanics
In this study (chapter 3 and 5), we downregulated Cx43 expression using 2,5-dihydroxychalcone
(chalcone) in a dose-dependent manner (see summary in figure 7.1). We have utilized two doses of
chalcone to downregulate HUVEC Cx43 expression and at the same time we computed tractions,
intercellular stresses, strain energy and cell velocities of HUVECs in both treated and untreated
conditions. Experiments were performed in static control and then repeated under fluid shear
stress with magnitude of 1 Pa. Our results reveal that Cx43 downregulation with low dose chalcone
yielded higher rms tractions and intercellular stresses in both static and fluid shear stress conditions.
While, we observed strain energy, maximum shear intercellular stress and cell velocities to be
decreased in static control under low dose chalcone, a reversed course is observed for all analysis
in low dose chalcone treatment. On the other hand, high dose chalcone showed decreased response
in all analysis conditions in both static and fluid shear stress experiments. This may imply that
downregulation of Cx43 on a drastic level may also reduces activity of other cell-cell junctions.
There have been other reports of donwregulation of Cx43 to be linked with tight junction ZO-1
and occludin [69]. Thus, low dose chalcone may upregulate other tight or gap junction proteins. It
is to be noted that, we have only looked into the expression of Cx43 junctions under the influence
of chalcone and we cannot rule out potential disruption or upregulation of other cell-cell junctions
in the presence of chalcone. We believe, the results we present here, will help us understand
better the influence of Cx43 donwregulation on EC mechanics and pathophysiology of a host of
cardiovascular diseases.
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Figure 7.1: Summary of the influence of Cx43 downregulation by chalcone on EC biomechanics
Impact of Cx43 Upregulation on Endothelium Biomechanics
In this study (chapter 4 and 5), we upregulated Cx43 expression using Retinoic Acid (RA) in a
dose dependent manner ( see summary in figure 7.2). We have utilized two doses of RA to upreg-
ulate HUVEC Cx43 expression and at the same time we computed tractions, intercellular stresses,
strain energy and cell velocities of HUVECs in both treated and untreated conditions. Experiments
were performed in static control and then repeated under fluid shear stress with magnitude of 1 Pa.
Our results reveal that at both low dose and high dose RA treatment, rms tractions, intercellular
stresses, strain energy and cell velocities were decreased compared to control conditions in both
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static and under fluid shear stress. This could potentially mean that Cx43 upregulation is inversely
linked with stress bearing cell-cell junctions such as tight junctions or adheres junctions. Also we
observed a more drastic decrease in low dose Cx43 upregulation compared to high dose RA treat-
ment, which could mean that the link between Cx43 upregulation and other junctions is dependent
on level of Cx43 expression changed. It has been reported that fluid shear stress upregulates Cx43
expression in osteocytes and similar phenomenon may be happening in our cases too [70]. In addi-
tion, this could potentially explain why the decrease in stresses is more drastic in low doses of RA
compared to high dose. Furthermore, additional studies needed to consider the effect of RA and
associated pathways that may potentially influence other cell-cell junctions in HUVECs as well.
The results we present here, we believe, will contribute greatly to the understanding of the role
Cx43 upregulation plays in the progression of a host of vascular diseases.
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Figure 7.2: Summary of the influence of Cx43 upegulation by retinoic acid on EC biomechanics
Impact of Different Level of Glucose on Endothelium Biomechanics
In this study, we cultured HUVECs in normal glucose ( 5.6 mmol/L of d-glucose), high level
glucose (20 mmol/L of d-glucose) and d-mannitol (5.6 mmol/L of d-glucose + 14.4 mmol/L of d-
mannitol) and then calculated tractions and intercellular stresses utilizing traction force microscopy
and monolayer stress microscopy, respectively. Our results reveal that (summary figure 7.3) hy-
perglycemia yielded decreased response of tractions, intercellular stresses, strain energy and cell
velocities compared to normal glucose and increased response compared to d-mannitol osmotic
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control conditions in HUVEC monolayers. However, decreased response of tractions and intercel-
lular stresses in HUVECs is completely reversed when fluid shear stress is introduced compared
to normal glucose condition. We believe this means two things, first, the influence of fluid shear
stress is very important while determining the impact of different level of glucose and second, the
concentration of glucose molecule could significantly impact endothelial intercellular stresses and
tractions generation. Decrease in tractions and intercellular stresses by d-mannitol and high level of
glucose compared to normal glucose also mean that not only high level of glucose is influential for
endothelium, but also high level of sugar substitutes such as sweeteners could be potentially harm-
ful for our vasculature in long trem exposure. Since, hyperglycemia is documented to be harmful
in diabetic patient, from our results we assume that diabetic endothelium may exert lower trac-
tions and intercellular stresses compared to a healthy endothelium. The reduction in intercellular
stresses may be related with the report that high glucose induced Cx43 and ZO-1 downregulation
in rat retinal endothelial cells and Cx43 upregulation protecting retinal endothelium from glucose
insult [66]. Taken all the factors together, we present here for the first time a unique report of en-
dothelial biomechanical strength under the influence of different level of glucose. We believe, our
results will help us better understand the specific role hyperglycemia plays in developing severe
cardiovascular diseases such as atherosclerosis or hypertension in diabetic patients.
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Figure 7.3: Summary of the influence of different level of glucose on EC biomechanics
Future Work
In this study, We have investigated the influence of gap junction Cx43 and different level of glu-
cose on HUVECs. In first part of our study, we only probed Cx43 junctions with two different
chemicals, but we didn’t investigate the potential influence chalcone and retinoic acid has on other
cell-cell junctions. Also, the effect of retinoic acid and chalcone alone on the endothelium needs
to be thoroughly investigated. From our analysis, we conclude that manipulating Cx43 expression
would change the endothelium biomechanical strength. Thus, Cx43 could potentially be a thera-
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peutic target for future in vivo studies. In addition, the interplay between Cx43 and ZO-1 reported
by others also remains an open question [69]. From our results, it seems like Cx43 expression
change may enact other tight or adherens junctions in play as adherens and tight junctions are be-
lieved to be the stress bearing junctions. In future, live staining of Cx43 or other junctions under the
influence of chalcone or retinoic acid may give us a clearer picture of endothelial biomechanical
response in real time. In second part of our study, We have investigated the influence of different
level of glucose in HUVEC stress generation but we didn’t stain for any specific junction. Further
studies are needed to measure the contribution of different cell-cell junctions under the influence of
different level of glucose treatment. Depending on different junctional expression, we may find a
potential therapeutic target to improve vascular health in diabetics as well as people with high car-
diovascular risk. Also, we have experimentally showed that sugar substitutes induce similar stress
response as high level of glucose. Thus, additional studies needed to get a more clearer picture of
endothelium interactions with sugar substitutes.
TFM and MSM methods are inexpensive, easy to execute in vitro experimental models and unlike
in vivo animal models, here we have certain degree of control of the environment. This easily
allow us to introduce as many as biochemical or biomechanical factors to probe any adherent cells
on a soft substrate. Also, our methods are capable of providing real-time data acquisition and
visualization to see changes happening in live cells. This may help us to provide better explana-
tions of physiological changes we observe in adherent cells under many different biochemical or
biomechanical conditions.
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